Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 18 studies | 81% ± 19% | |
peripheral blood | 17 studies | 92% ± 7% | |
brain | 14 studies | 61% ± 26% | |
intestine | 13 studies | 86% ± 22% | |
liver | 7 studies | 78% ± 27% | |
kidney | 7 studies | 81% ± 22% | |
eye | 7 studies | 74% ± 27% | |
bone marrow | 5 studies | 95% ± 3% | |
heart | 5 studies | 37% ± 19% | |
lymph node | 4 studies | 96% ± 3% | |
breast | 4 studies | 96% ± 1% | |
uterus | 3 studies | 99% ± 1% | |
prostate | 3 studies | 100% ± 0% | |
esophagus | 3 studies | 83% ± 12% | |
skin | 3 studies | 95% ± 3% | |
adipose | 3 studies | 91% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 1012794.35 | 258 / 258 | 100% | 20765.35 | 230 / 230 |
kidney | 100% | 1639704.40 | 89 / 89 | 99% | 22274.93 | 895 / 901 |
brain | 100% | 1270414.24 | 2636 / 2642 | 99% | 18472.91 | 701 / 705 |
liver | 100% | 1185991.35 | 225 / 226 | 100% | 15690.36 | 404 / 406 |
prostate | 99% | 644598.71 | 243 / 245 | 100% | 16779.15 | 501 / 502 |
stomach | 100% | 705560.71 | 358 / 359 | 99% | 16681.83 | 282 / 286 |
breast | 100% | 579133.58 | 457 / 459 | 98% | 12073.05 | 1095 / 1118 |
intestine | 99% | 674648.70 | 954 / 966 | 98% | 16612.28 | 519 / 527 |
esophagus | 97% | 511021.65 | 1403 / 1445 | 100% | 12904.73 | 183 / 183 |
pancreas | 98% | 332651.52 | 320 / 328 | 99% | 13652.70 | 177 / 178 |
bladder | 95% | 494999.33 | 20 / 21 | 97% | 16315.15 | 491 / 504 |
thymus | 94% | 412976.61 | 612 / 653 | 99% | 16305.73 | 598 / 605 |
skin | 95% | 368565.26 | 1713 / 1809 | 97% | 13416.62 | 460 / 472 |
lung | 91% | 303164.54 | 524 / 578 | 95% | 10654.05 | 1094 / 1155 |
uterus | 85% | 263118.92 | 144 / 170 | 97% | 11281.35 | 444 / 459 |
ovary | 71% | 219378.11 | 128 / 180 | 100% | 14626.29 | 430 / 430 |
eye | 0% | 0 | 0 / 0 | 100% | 22124.25 | 80 / 80 |
heart | 100% | 1762080.09 | 861 / 861 | 0% | 0 | 0 / 0 |
muscle | 100% | 958176.62 | 803 / 803 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 30600.34 | 1 / 1 |
adipose | 99% | 593980.30 | 1194 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 7380.78 | 44 / 45 |
spleen | 95% | 351977.34 | 228 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 86% | 258541.71 | 1151 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 72% | 6039.93 | 21 / 29 |
peripheral blood | 28% | 79137.48 | 264 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0055093 | Biological process | response to hyperoxia |
GO_0042776 | Biological process | proton motive force-driven mitochondrial ATP synthesis |
GO_1902600 | Biological process | proton transmembrane transport |
GO_0015986 | Biological process | proton motive force-driven ATP synthesis |
GO_0005753 | Cellular component | mitochondrial proton-transporting ATP synthase complex |
GO_0045263 | Cellular component | proton-transporting ATP synthase complex, coupling factor F(o) |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0046933 | Molecular function | proton-transporting ATP synthase activity, rotational mechanism |
GO_0005515 | Molecular function | protein binding |
Gene name | MT-ATP6 |
Protein name | ATP synthase subunit a (F-ATPase protein 6) |
Synonyms | MTATP6 ATP6 ATPASE6 |
Description | FUNCTION: Mitochondrial membrane ATP synthase (F(1)F(0) ATP synthase or Complex V) produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. F-type ATPases consist of two structural domains, F(1) - containing the extramembraneous catalytic core and F(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. Key component of the proton channel; it may play a direct role in the translocation of protons across the membrane. |
Accessions | ENST00000361899.2 P00846 |